RBBP6 is highly up-regulated and is correlated with poor clinical prognosis in a variety of cancers, such as esophageal cancer28, breast cancer29, lung cancer30, and cervical cancer31, playing a role in regulation of cell proliferation, cell cycle, and cell apoptosis. Here, RBBP6 is linked to cancer.